OncLive.com
@onclive
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.
ID: 43051682
http://www.onclive.com 28-05-2009 05:04:27
110,110K Tweet
46,46K Takipçi
1,1K Takip Edilen
Pembrolizumab Plus Bevacizumab/CAPOX Yields Responses in pMMR/MSS mCRC With High TILs #crcsm #oncology #ESMOGI24 ESMO - Eur. Oncology Tougeron David onclive.com/view/pembroliz…